- Bortezomib, sold
under the
brand name
Velcade among others, is an anti-cancer
medication used to
treat multiple myeloma and
mantle cell lymphoma. This...
- research. It is
particularly known for
bringing bortezomib (marketed as
Velcade)
through clinical trials to
approval for
treatment of
patients with multiple...
-
Darzalex Eprex Erleada Imbruvica Procrit Rybrevant Talvey Tecvayli Valchlor Velcade Yondelis Zytiga Cardiovascular, metabolism, and
retina therapies Xarelto...
- present".
Green tea
interferes with the
chemotherapy drug
bortezomib (
Velcade) and
other boronic acid-based
proteasome inhibitors, and
should be avoided...
- drug
against multiple myeloma. When
bortezomib is used by the
trade name
Velcade, the
combination is
called Vel/Dex (or Vel-Dex or Veldex).
Bortezomib is...
- in
cancer drug research, for US$8.8 billion. The
acquisition brought in
Velcade, a drug
indicated for
hematological malignancies, as well as a portfolio...
-
brand names and lower-case
letters for
generic drug names, e.g., VRd for
Velcade (brand name for bortezomib),
Revlimid (brand name for lenalidomide) and...
-
including most
commonly with
thalidomide (Thal-dex), lenalidomide,
bortezomib (
Velcade, Vel-dex), or a
combination of
doxorubicin (Adriamycin) and vincristine...
-
Veklury velafermin (USAN)
velaglucerase alfa (USAN)
velaresol (INN)
Velban Velcade Veletri veliflapon (USAN)
velimogene aliplasmid (USAN)
veliparib (USAN...
-
Bosutinib (Bosulif)
Ponatinib (Iclusig)
Asciminib (Scemblix)
Bortezomib (
Velcade) is an apoptosis-inducing
proteasome inhibitor drug that
causes cancer...
